Revisiting the blind spot of substandard and fake drugs as drivers of antimicrobial resistance in LMICs

Author:

Gulumbe Bashar H.1,Adesola Ridwan O.2ORCID

Affiliation:

1. Department of Microbiology, Faculty of Science, Federal University, Birnin Kebbi, Kebbi State

2. Department of Veterinary Medicine, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria

Abstract

One of the most significant risks to public health is ongoing antimicrobial resistance (AMR). Substandard and fraudulent medications, particularly in low- and middle-income countries (LMICs), are thought to have a role in the genesis and spread of AMR. There are numerous reports concerning the availability of subpar pharmaceuticals in developing countries, with no scientific evidence as to what exactly is included in some of the prescriptions supplied there. These counterfeit and inferior pharmaceuticals are a financial burden of up to US$200 billion, causing thousands of patient deaths, endangering both individual and public health,and undermining patient trust in the healthcare system. Poor quality and counterfeit antibiotics are often disregarded as possible causes of AMR in AMR studies. Therefore, we examined the issue of fake drugs in LMICs and its possible links to the emergence and spread of AMR.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,Surgery

Reference7 articles.

1. Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries: a systematic review and meta-analysis;Ozawa;JAMA Netw Open,2018

2. Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?;Zabala;BMJ Global Health,2022

3. Substandard/counterfeit antimicrobial drugs;Kelesidis;Clin Microbiol Rev,2015

4. Drug quality, a contributor to drug resistance?;Taylor;Lancet,1995

5. Blood culture isolates from children admitted to Medical Unit III, Yangon Children’s Hospital, 1998;Shwe;Southeast Asian J Trop Med Public Health,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3